spn3
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Aug 1, 2022 (NCT05535868)
Timeline
No events for the selected filters.
Indications
Mechanism of action
- Streptococcus pneumoniaeImmunity, active
Streptococcus pneumoniae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06731374 | Phase 4 | Jan 31, 2025 | University of Liverpool, University of Oxford |
| NCT05535868 | N/A | Aug 1, 2022 | Merck, University of Liverpool |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Liverpool | Academic/Hospital | 2 | 1 | 2 | 2022 |
| Merck | For profit | 1 | 0 | 1 | 2022 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1